A National Registry For Patients With Hidradenitis Suppurativa

Montefiore Medicine Academic Health System

Status: Completed

Conditions: Hidradenitis Suppurativa

Study type: Observational

Funder types: Other

Identifiers

NCT03289585

2014-3835 (AECOM)

Details and patient eligibility

About

The goal of this study is to get a better understanding of the skin condition, Hidradenitis Suppurativa, and to find out how the disease affects quality of life. The investigators hope this information will help improve treatment for this skin condition.

Full description

The goal of this study is to get a better understanding of the skin condition, Hidradenitis Suppurativa, and to find out how the disease affects quality of life. The investigators will utilize a compilation of validated questionnaires including the Beck Depression Inventory form, Dermatology Life Quality Index (DLQI), Skindex, SF-36 health survey, the Quality of Life Enjoyment and Satisfaction Questionnaire- short form (Q-LES-Q-SF) and the Employment/Productivity Health Economic Questionnaire as well as other relevant clinical data. The investigators will additionally collect a modified Hidradenitis Suppurativa Lesion, Area, and Severity Index (HS-LASI) (or other appropriate disease severity score as determined by the team) from the physician of each enrollee. The investigators hope this information will help improve treatment for this skin condition.

Enrollment: 400 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects 18-99 years of age who have a diagnosis of Hidradenitis Suppurativa (as deemed by a physician at the Montefiore Hidradenitis Suppurativa Treatment Center)

Exclusion criteria

• Patients without a diagnosis of Hidradenitis Suppurativa or under the age of 18
• Patients who are unable to answer given questions within the 6 surveys
• Patient who are unable to be clinically evaluated by a Montefiore physician

Trial design

400 participants in 1 patient group

Hidradenitis Suppurativa Cohort

Description:

Patients with Hidradenitis Suppurativa (ages 18-99 years old) will be asked to complete a series of questionnaires on how Hidradenitis Suppurativa impacts quality of life.